Industry Analysis & Industry Trends
Thin film drug manufacturers have experienced rapid revenue growth over the past five years, and this trend is expected to continue over the next five as the technology gains market acceptance. As a result, both brand name and generic pharmaceutical manufacturers are expected to offer thin film versions of their drugs and increase the industry's scope over the coming years.... purchase to read more
Industry Report - Industry Investment Chapter
Capital intensity in the Thin Film Drug Manufacturing industry is high; for every dollar spent on wages, IBISWorld estimates that $0.65 is spent on capital. The equipment needed to test and produce drugs requires a great deal of expenditure. While the average wage is relatively high, total wages only represent 11.0% of industry revenue. In comparison, depreciation accounts for 7.1% of industry revenue. Costs to develop new technologies like thin film can be so extensive that some companies have partnered with firms that specialize in producing water-soluble strips. For example, Reckitt Benckiser has paired with MonoSol to produce its thin film version of Suboxone, a drug to battle opiate dependence... purchase to read more